Posted on January 12, 2017 by Sitemaster
In September last year, Hamdy et al. published the initial results of the ProtecT trial — a trial designed to compare overall outcomes at 10 years among > 1,600 men diagnosed with low- and intermediate-risk, localized prostate cancer and randomized to treatment by surgery, by external beam radiation therapy, or by active monitoring (a very basic form of active surveillance). … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Treatment | Tagged: outcomes, ProtecT, radiation, surgery, trial. monitoring | Leave a comment »
Posted on September 17, 2016 by Sitemaster
The following official statement was issued on September 15 by the American Society for Radiation Oncology (ASTRO): … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: guideline, localized, ProtecT, Treatment | 2 Comments »
Posted on September 15, 2016 by Sitemaster
We have already commented on the oncologic outcomes of patients enrolled in the ProtecT trial and published in today’s issue of the New England Journal of Medicine. In this commentary we shall comment on the separate paper that addresses patient-reported outcomes from that trial. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: health-related, outcome, outcomes, ProtecT, quality of life, side effects | 7 Comments »
Posted on September 15, 2016 by Sitemaster
So the majority of the readers of The “New” Prostate Cancer InfoLink will be well aware that we have never had data from a large, randomized clinical trial comparing the outcomes of the commonest first-line forms of management of men diagnosed with localized prostate cancer … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: first line, monitoring, outcome, ProtecT, radiation, surgery, trial | 9 Comments »
Posted on August 26, 2014 by Sitemaster
Many readers of this blog will be interested to look through the data on the preliminary study design and diagnostic and baseline results of the randomized, phase III ProtecT trial that have just been reported in The Lancet Oncology. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: active surveillance, ProtecT, radiotherapy, surgery | Leave a comment »
Posted on December 8, 2009 by Sitemaster
The Prostate Testing for Cancer and Treatment (ProtecT) trial is being implemented in the UK to evaluate outcomes of three different types of treatment: surgery, radiation, and “active monitoring” in the management of localized prostate cancer. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: incidence, ProtecT, risk, screening, UK | Leave a comment »
THE "NEW" PROSTATE CANCER INFOLINK 